Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
48 participants
INTERVENTIONAL
2021-04-10
2022-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Yoga and Aerobic Exercise in Psychosis
NCT01207219
Effects of Ba Duan Jin Training for Older People
NCT06550661
Traditional Exercise RCT in Visually Impaired Adults
NCT07265024
Randomized Trial of Exercise and Social Interaction in a Community-Based Sample of Non-Demented Chinese Elders
NCT01696019
Temporal Relations and Exercise Interventions of Various Gait and Cognitive Domains in Older Adults
NCT03839563
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Baduanjin exercise group
The intervention group will practice Badunjin in a group which include 6-8 participants and one trained medical staff. The Baduanjin is an ancient Chinese mind-body exercise, which comprised of eight simple movements.
The sessions will take place twice a week, 60 minutes per session for a total duration of 12 weeks
Baduanjin exercise program
The sessions includes 10-minute warm-up, 40-minute Baduanjin exercise and 10-minute cool down.
Control group
The control group will receive brisk walking activities. The sessions will take place twice a week, 60 minutes per session for a total duration of 12 weeks
Brisk walking program
The sessions includes 10-minute warm-up, 40-minute brisk walking and 10-minute cool down.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Baduanjin exercise program
The sessions includes 10-minute warm-up, 40-minute Baduanjin exercise and 10-minute cool down.
Brisk walking program
The sessions includes 10-minute warm-up, 40-minute brisk walking and 10-minute cool down.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Independent adult aged 40 years or older in the day-care center.
* Having a stable mental status without shift in medication and keep in same dose for at least one month.
Exclusion Criteria
* Visual or auditory impairment that precludes completion of assessment.
* Acute psychosis requiring hospitalization.
* Presence of severe withdrawal or profound cognitive disability that cause difficulties in following instructions.
* Participating in another clinical trial at the same time.
40 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Taiwan University
OTHER
Chang Gung Memorial Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Chang Gung Memorial Hospital, Kaohsiung Medical Center
Kaohsiung City, , Taiwan
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
202000817B0
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.